NASDAQ:ACAD   ACADIA Pharmaceuticals Inc.
3
Looks to be a potential retest of medium term break in downtrend. Confirmed by reversal around the 36 level.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.